Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

100 ML eptifibatide 0.75 MG/ML Injection

Known as: EPTIFIBATIDE 0.75MG/ML INJ, EPTIFIBATIDE 0.75 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION, EPTIFIBATIDE 0.75MG/ML INJ [VA Product] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Background/Aims: Eptifibatide is a parenteral glycoprotein IIb-IIIa inhibitor that prevents platelet aggregation. Although… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2004
2004
Clinically used GPIIb/IIIa blockers are ligand mimetics, and thereby their binding can induce conformational changes of the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?